Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Orphai Therapeutics

Clinical trials sponsored by Orphai Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Inhaled sirolimus trial aims to ease breathing in lung scar patients Results expected Jul 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • Inhaled sirolimus trial aims to ease breathing in lung scar patients

    Disease control Recruiting now

    This Phase 2 trial tests an inhaled drug called LAM-001 (sirolimus) in 85 adults who have pulmonary hypertension (high blood pressure in the lungs) along with interstitial lung disease (lung scarring). The study compares the drug to a placebo to see if it improves blood flow in t…

    Phase 2 • Sponsor: OrphAI Therapeutics • Aim: Disease control

    Last updated Aug 05, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space